GlaxoSmithKline

GlaxoSmithKline logo
πŸ‡¬πŸ‡§United Kingdom
Ownership
Public
Established
1929-01-01
Employees
70.2K
Market Cap
$90B
Website
http://www.gsk.com
Introduction

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general med...

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

First Posted Date
2023-05-26
Last Posted Date
2024-12-04
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
300
Registration Number
NCT05878717
Locations
πŸ‡¬πŸ‡§

GSK Investigational Site, London, United Kingdom

Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

First Posted Date
2023-05-11
Last Posted Date
2024-08-27
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
711
Registration Number
NCT05855200
Locations
πŸ‡¬πŸ‡§

GSK Investigational Site, Sutton, United Kingdom

A Dose-Finding Study to Evaluate the Efficacy and Safety of GSK3858279 in Adults With Knee Osteoarthritis (OA) Pain

Phase 2
Active, not recruiting
Conditions
Interventions
First Posted Date
2023-05-03
Last Posted Date
2024-12-04
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
314
Registration Number
NCT05838742
Locations
πŸ‡¬πŸ‡§

GSK Investigational Site, Norwich, United Kingdom

A Study to Evaluate Efficacy and Safety of GSK3858279 in Diabetic Peripheral Neuropathic Pain

Phase 2
Active, not recruiting
Conditions
Interventions
First Posted Date
2023-05-03
Last Posted Date
2024-11-18
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
145
Registration Number
NCT05838755
Locations
πŸ‡¬πŸ‡§

GSK Investigational Site, Wrexham, United Kingdom

A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults

First Posted Date
2023-04-21
Last Posted Date
2024-03-01
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
1256
Registration Number
NCT05823974
Locations
πŸ‡ΏπŸ‡¦

GSK Investigational Site, East London, South Africa

Safety of Herpes Zoster Subunit (HZ/su) Vaccine During Pregnancy in Adult Women With Immunocompromised Conditions

Not yet recruiting
Conditions
Interventions
First Posted Date
2023-04-13
Last Posted Date
2023-04-13
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
2844
Registration Number
NCT05811754

Green (Sustainable) VENTOLIN - Pharmacokinetics (PK) Study in Healthy Participants

Phase 1
Completed
Conditions
Interventions
First Posted Date
2023-03-30
Last Posted Date
2023-11-29
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
28
Registration Number
NCT05791565
Locations
πŸ‡³πŸ‡±

GSK Investigational Site, Groningen, Netherlands

Drug Interaction Assessment of GSK3882347 in Healthy Participants Aged 18 to 65 Years

Phase 1
Completed
Conditions
Interventions
First Posted Date
2023-03-08
Last Posted Date
2024-11-07
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
27
Registration Number
NCT05760261
Locations
πŸ‡¬πŸ‡§

GSK Investigational Site, Cambridge, United Kingdom

A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

Phase 3
Recruiting
Conditions
Interventions
First Posted Date
2023-03-07
Last Posted Date
2024-05-28
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
292
Registration Number
NCT05757102
Locations
πŸ‡ΉπŸ‡·

GSK Investigational Site, Konyaalti, Turkey

A Study of Dostarlimab in Untreated dMMR/MSI-H Locally Advanced Rectal Cancer

Phase 2
Recruiting
Conditions
Interventions
First Posted Date
2023-02-10
Last Posted Date
2024-02-20
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
150
Registration Number
NCT05723562
Locations
πŸ‡¬πŸ‡§

GSK Investigational Site, Sutton, United Kingdom

Β© Copyright 2024. All Rights Reserved by MedPath